Work

Cost‐effectiveness of rituximab as maintenance treatment for relapsed follicular lymphoma: results of a population‐based study

Year: 2014

Type: article

Source: European Journal Of Haematology

DOI: 10.1111/ejh.12264

Authors: Hedwig M. Blommestein, Djamila E. Issa, Marjolein Pompen, Gerhard Ten Hoor, Mels Hogendoorn, Peter Joosten, Sonja Zweegman, Peter C. Huijgens, Carin A. Uyl‐de Groot

Institutions: Erasmus University Rotterdam, Amsterdam UMC Location Vrije Universiteit Amsterdam, Bristol-Myers Squibb (Netherlands), Roche (Netherlands), Medisch Centrum Leeuwarden

Language: English

Topic: Health Systems, Economic Evaluations, Quality of Life

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Sanofi, Celgene

OpenAlex ID: W2138167692

FWCI: 7.503

Cites: 20

Cited by: 17

Related to: 10